Introduction to 45 CFR 46.110
The 45 CFR 46.110 regulation outlines the procedures for expedited review of research studies involving human subjects. This regulation is crucial for ensuring that research studies are conducted in an ethical and compliant manner.
The expedited review process allows for a more streamlined review of certain types of research studies, such as those that pose minimal risk to human subjects. This process helps to facilitate the conduct of research while still ensuring the protection of human subjects.
Expedited Review Categories
The 45 CFR 46.110 regulation identifies several categories of research studies that are eligible for expedited review. These categories include research studies that involve the use of existing data, research studies that involve the use of surveys or interviews, and research studies that involve the use of minimal risk interventions.
Each category has specific criteria that must be met in order for the research study to be eligible for expedited review. For example, research studies that involve the use of existing data must ensure that the data is de-identified and that the research study does not involve any risk to human subjects.
Procedures for Expedited Review
The procedures for expedited review are outlined in the 45 CFR 46.110 regulation. The regulation requires that the Institutional Review Board (IRB) review the research study to ensure that it meets the criteria for expedited review.
The IRB must also ensure that the research study is conducted in accordance with the federal regulations and that the rights and welfare of human subjects are protected. The IRB may request additional information or modifications to the research study in order to ensure compliance with the regulations.
Benefits of Expedited Review
The expedited review process offers several benefits to researchers, including a more streamlined review process and a faster turnaround time for approval. This allows researchers to begin their studies more quickly and to make progress on their research goals.
The expedited review process also helps to reduce the administrative burden on researchers and IRBs, allowing them to focus on more complex and high-risk research studies. This helps to ensure that research studies are conducted in an efficient and effective manner.
Compliance with 45 CFR 46.110
Compliance with the 45 CFR 46.110 regulation is crucial for researchers and institutions. Failure to comply with the regulation can result in serious consequences, including the loss of funding and the damage to reputation.
Researchers and institutions must ensure that they understand the requirements of the regulation and that they have policies and procedures in place to ensure compliance. This includes providing training to researchers and IRB members on the expedited review process and the criteria for expedited review.
Frequently Asked Questions
What is the purpose of the 45 CFR 46.110 regulation?
The purpose of the 45 CFR 46.110 regulation is to outline the procedures for expedited review of research studies involving human subjects.
What types of research studies are eligible for expedited review?
Research studies that involve minimal risk to human subjects, such as those that use existing data or surveys, are eligible for expedited review.
What is the role of the IRB in the expedited review process?
The IRB reviews the research study to ensure that it meets the criteria for expedited review and that the rights and welfare of human subjects are protected.
How long does the expedited review process typically take?
The expedited review process is typically faster than the full board review process, with a turnaround time of several days to several weeks.
What are the consequences of non-compliance with the 45 CFR 46.110 regulation?
Non-compliance with the 45 CFR 46.110 regulation can result in serious consequences, including the loss of funding and the damage to reputation.
Where can I find more information about the 45 CFR 46.110 regulation?
More information about the 45 CFR 46.110 regulation can be found on the website of the Office for Human Research Protections (OHRP) or by contacting an IRB specialist.